|
Patent Reform
America needs to protect and fully enforce intellectual property rights, without which the biotechnology industry would be irrevocably harmed. Inventions in biotechnology are entitled to the same patent term as inventions in other technologies. However, due to the added step of Food and Drug Administration (FDA) regulatory review, biotechnology inventions lose eight to ten years of patent life. BIO advocates day-for-day restoration of all patent term lost due to regulatory delays.
Letter regarding "Patent Quality Improvement: Post-Grant Opposition" (July 8, 2004)
to Committee on the Judiciary, Subcommittee on Courts, the Internet and Intellectual Property
The Honorable Lamar Smith, Chairman and The Honarable Howard Berman, Ranking Minority Member
Read the letter (432 KB PDF)
|
